ROS levels were significantly higher in the heterozygous T1D patients (n = 10) compared to wild-type T1D patients (n = 6) following treatments with TNF-α and TNF-α+fMLP (p < 0.001). The gene discussed is FPR1; the disease is type 1 diabetes mellitus.